MondayJun 02, 2025 11:15 am

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Increases Ownership of Bollinger Motors to 95%, Resolves Receivership

Mullen Automotive (NASDAQ: MULN) has acquired an additional 21% stake in Bollinger Motors, bringing its total ownership to 95% and increasing shareholder equity by approximately $3.5 million. The move follows Mullen’s resolution of outstanding claims and debt that had placed Bollinger under court-ordered receivership, a case now dismissed with prejudice. Bollinger will continue operating independently under Mullen’s ownership, with its commercial EV lineup—led by the all-electric B4 Chassis Cab—receiving full support for sales, service, and warranty. Mullen plans to leverage synergies to accelerate the B4’s development and drive growth within the commercial EV space. To view the full press release, visit…

Continue Reading

MondayJun 02, 2025 10:15 am

QualityStocksNewsBreaks – Ucore Rare Metals Inc. (TSXV: UCU) (OTCQX: UURAF) Secures Definitive $18.4M DoD Award to Build First Commercial RapidSX(TM) System

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) has finalized the contract for an $18.4 million award from the U.S. Department of Defense to construct its first commercial-scale RapidSX(TM) rare earth separation system and infrastructure at the Strategic Metals Complex (SMC) in Alexandria, Louisiana. This brings total non-repayable funding under Ucore’s existing OT Agreement to $22.4 million. The funds will support engineering, permitting, and construction of a RapidSX(TM) machine and supporting systems capable of processing individual rare earth oxides starting in the second half of 2026. A groundbreaking ceremony was held May 29 with local, state, and federal leaders in attendance. The…

Continue Reading

MondayJun 02, 2025 9:20 am

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Posts Record Q1 Revenue, Advances AVERSA Fentanyl Development

Nutriband (NASDAQ: NTRB) reported first-quarter revenue of $667,000, a 63% year-over-year increase driven by expanded kinesiology tape production through its Pocono Pharma subsidiary and growing retail presence at Target, Walmart, Walgreens, and CVS. The company continues to prioritize shareholder value by scaling Pocono’s output through penetration pricing strategies while advancing development of AVERSA Fentanyl, an abuse-deterrent transdermal opioid patch. A newly formalized partnership with Kindeva Drug Delivery will support shared development costs in exchange for milestone payments as AVERSA moves toward regulatory approval. The product is projected to reach peak U.S. sales of $80 million to $200 million annually. To view…

Continue Reading

MondayJun 02, 2025 9:00 am

QualityStocksNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Launches Final Spiral Tests Ahead of Montauban Gold-Silver Production

ESGold (CSE: ESAU) (OTCQB: ESAUF) has begun final spiral concentration tests at its Montauban Gold-Silver Project in Quebec, marking a major milestone toward initiating production later this year. Conducted on high-grade railbed material—geologically distinct from the Anacon tailings—the tests target a concentrate representing under 0.3% of total mass while capturing over 50% of contained gold and silver. If successful, the process could enable direct on-site bullion pours, cutting cyanide use and accelerating cash flow. Final lab results are expected within a month, as commissioning of the Montauban plant continues to advance. To view the full press release, visit https://ibn.fm/VCLgv About…

Continue Reading

FridayMay 30, 2025 3:41 pm

QualityStocksNewsBreaks – Innovation in Motion: Massimo Group (NASDAQ: MAMO) Launches Fully Digital Retail Platform

Massimo Group (NASDAQ: MAMO) is entering a new growth phase with the launch of a comprehensive digital retail platform. This move is designed to simplify the purchasing process for its UTVs, ATVs, and mini-bikes, while expanding the company’s national sales footprint. “The platform enables customers to complete transactions online, including financing, titling, and checkout, providing a fully digital experience,” reads a recent article discussing the launch. “Massimo expects this shift to unlock greater scalability, reduce sales friction, and drive a significant increase in annual revenue.” To view the full article, visit https://ibn.fm/wNk6H About Massimo Group Massimo Group is a manufacturer and distributor…

Continue Reading

FridayMay 30, 2025 3:03 pm

QualityStocksNewsBreaks – Adageis’ AI-Powered Insights Aim to Improve Outcomes, Revenue Forecasting

Adageis, a forward-thinking healthcare technology company, has a comprehensive suite of AI-powered solutions aimed at providers shifting from fee-for-service to value-based care. “At the core of the company’s offering is its ProActive Care Platform, which combines predictive analytics with real-time data integration to improve both clinical and financial outcomes,” reads a recent article. “The platform’s Patented Risk Engine (‘PRE’) enables users to forecast revenue based on quality performance metrics and patient care patterns. For providers managing contracts that tie compensation to outcomes, these insights are increasingly important.” To view the full article, visit https://ibn.fm/tNmXw About Adageis Adageis is a healthcare…

Continue Reading

FridayMay 30, 2025 9:20 am

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q1 Revenue Growth Driven by CDMO Contracts, Net Loss Narrows

Scinai Immunotherapeutics (NASDAQ: SCNI) reported first quarter 2025 financial results, posting $586K in revenue, up from zero in the prior-year period, reflecting continued expansion of its CDMO business. R&D expenses declined to $1.3M from $1.6M, while marketing, general and administrative costs held steady at $500K. The company recorded a $1.6M net loss, improving from a $2.2M loss in Q1 2024, aided by reduced R&D and financial expenses. Cash and equivalents totaled $1M at quarter-end, down from $2M a year earlier. To view the full press release, visit https://ibn.fm/yofBq About Scinai Immunotherapeutics Ltd. Scinai is a biopharmaceutical company with two complementary…

Continue Reading

FridayMay 30, 2025 9:10 am

QualityStocksNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Closes $1 Million Private Placement with HCI

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) has closed a US$1.008 million non-brokered private placement with major shareholder Hosken Consolidated Investments Limited (“HCI”) via its subsidiary Deepkloof Limited. The transaction, completed May 29, 2025, involved the issuance of 800,000 common shares at US$1.26 per share, restoring HCI’s ownership to 26%. Proceeds will support pre-construction and engineering work at the Waterberg Project in South Africa, along with general corporate purposes. As HCI is a related party, the deal qualifies for exemptions under MI 61-101 and was negotiated on an expedited basis. To view the full press release, visit https://ibn.fm/KvEH7 About Platinum…

Continue Reading

ThursdayMay 29, 2025 2:10 pm

QualityStocksNewsBreaks – Tesla Inc. (NASDAQ: TSLA) Urges Senate to Preserve Clean Energy Tax Credits Amid Legislative Threats

Tesla (NASDAQ: TSLA) is actively lobbying the U.S. Senate to retain key clean energy tax credits that are under threat from a House-passed reconciliation bill. The proposed legislation aims to roll back significant portions of the Inflation Reduction Act, including the 30% tax credits for residential solar installations and clean energy projects, which are currently set to expire in 2032. Tesla's energy division, which reported a 67% year-over-year revenue increase to $2.7 billion in Q1 2025, heavily relies on these incentives. The company warns that abrupt termination of these credits could jeopardize America's energy independence and hinder the deployment of…

Continue Reading

ThursdayMay 29, 2025 2:00 pm

QualityStocksNewsBreaks – NVIDIA Corp. (NASDAQ: NVDA) Climbs Despite Cautious Forecast, Driven by AI Demand and Investor Confidence

NVIDIA (NASDAQ: NVDA) is experiencing a stock surge, rising 5.3% on Thursday, even after issuing a cautious forecast for fiscal 2026. The company reported impressive revenue growth of 126% in fiscal 2024 and 114% in fiscal 2025, underscoring the robust demand for its AI and data center products. Analysts attribute the stock's resilience to Nvidia's pivotal role in the AI sector, with ongoing investments in data centers and AI infrastructure fueling optimism. Despite the tempered outlook, investors remain bullish on Nvidia's long-term growth prospects in the evolving tech landscape. As of May 29, 2025, Nvidia's stock is trading at $140.04,…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered